Literature DB >> 23212181

Impact of cardiac devices on the quality of life in pediatric patients.

Richard J Czosek1, William J Bonney, Amy Cassedy, Douglas Y Mah, Ronn E Tanel, Jason R Imundo, Anoop K Singh, Mitchell I Cohen, Christina Y Miyake, Kara Fawley, Bradley S Marino.   

Abstract

BACKGROUND: Cardiac rhythm devices are increasingly used in the pediatric population, although their impact on quality of life (QOL) is poorly understood. The purpose of this study was to compare (QOL) scores among pediatric device patients, healthy controls, and congenital heart disease (CHD) patients and determine the key drivers of QOL in pediatric device patients. METHODS AND
RESULTS: Multicenter, cross-sectional study at 8 pediatric centers of subjects aged 8 to 18 years with either a pacemaker or defibrillator was carried out. Patient-parent pairs completed the Pediatric Quality of Life Inventory and Pediatric Cardiac Quality of Life Inventory. QOL outcomes in device patients were compared with healthy controls and patients with various forms of CHD. Structural equation modeling was used to test for differences in Pediatric Cardiac Quality of Life Inventory scores among (1) device type, (2) presence of CHD, and (3) hypothesized key drivers of QOL. One hundred seventy-three patient-parent pairs (40 defibrillators/133 pacemakers) were included. Compared with healthy controls, patients with devices and their parents reported significantly lower Pediatric Quality of Life Inventory scoring. Similarly, compared with patients with mild forms of CHD, parents and patients with devices reported significantly lower Pediatric Cardiac Quality of Life Inventory scores and were similar to patients with more severe CHD. Key drivers of patient QOL were presence of implantable cardioverter-defibrillator and CHD. For patients, self-perception was a key driver of lower QOL, whereas for parents behavioral issues were associated with lower QOL.
CONCLUSIONS: Patient QOL is significantly affected by the presence of cardiac rhythm devices. Whether these effects can be mitigated through the use of psychotherapy needs to be assessed.

Entities:  

Mesh:

Year:  2012        PMID: 23212181     DOI: 10.1161/CIRCEP.112.973032

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  16 in total

1.  Optogenetics for suppression of cardiac electrical activity in human and rat cardiomyocyte cultures.

Authors:  Udi Nussinovitch; Lior Gepstein
Journal:  Neurophotonics       Date:  2015-06-23       Impact factor: 3.593

2.  Prediction by clinicians of quality of life for children and adolescents with cardiac disease.

Authors:  John M Costello; Kathleen Mussatto; Amy Cassedy; Jo Wray; Lynn Mahony; Sarah A Teele; Kate L Brown; Rodney C Franklin; Gil Wernovsky; Bradley S Marino
Journal:  J Pediatr       Date:  2015-03       Impact factor: 4.406

3.  Electrocardiographic Markers of Appropriate Implantable Cardioverter-Defibrillator Therapy in Young People with Congenital Heart Diseases.

Authors:  Dunia Bárbara Benítez Ramos; Michel Cabrera Ortega; Jesús Castro Hevia; Margarita Dorantes Sánchez; Ailema Amelia Alemán Fernández; Osmin Castañeda Chirino; Marlenis Cruz Cardentey; Frank Martínez López; Roylan Falcón Rodríguez
Journal:  Pediatr Cardiol       Date:  2017-09-04       Impact factor: 1.655

4.  Systematic psychosocial screening in a paediatric cardiology clinic: clinical utility of the Pediatric Symptom Checklist 17.

Authors:  Kari L Struemph; Lydia R Barhight; Deepika Thacker; Erica Sood
Journal:  Cardiol Young       Date:  2015-10-01       Impact factor: 1.093

Review 5.  Making better scar: Emerging approaches for modifying mechanical and electrical properties following infarction and ablation.

Authors:  Jeffrey W Holmes; Zachary Laksman; Lior Gepstein
Journal:  Prog Biophys Mol Biol       Date:  2015-11-23       Impact factor: 3.667

6.  VT ablation: New Developments and Approaches.

Authors:  Zhiyu Ling; Adithya Hari; Harikrishna Tandri
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-04

7.  The relationship of patient medical and laboratory characteristics to changes in functional health status in children and adolescents after the Fontan procedure.

Authors:  Brian W McCrindle; Victor Zak; Roger E Breitbart; Lynn Mahony; Peter Shrader; Wyman W Lai; Kristin M Burns; Steven D Colan; Richard V Williams; David Goldberg; Kevin D Hill; Svetlana Khaikin; Andrew M Atz
Journal:  Pediatr Cardiol       Date:  2013-11-22       Impact factor: 1.655

8.  Health-related quality of life assessment in children followed in a cardiomyopathy clinic.

Authors:  Melanie R Friess; Bradley S Marino; Amy Cassedy; Ivan Wilmot; John L Jefferies; Angela Lorts
Journal:  Pediatr Cardiol       Date:  2014-10-07       Impact factor: 1.655

9.  Toward detection of conduction tissue during cardiac surgery: Light at the end of the tunnel?

Authors:  Frank B Sachse; Jordan Johnson; Brian Cottle; Abhijit Mondal; Robert Hitchcock; Aditya K Kaza
Journal:  Heart Rhythm       Date:  2020-07-10       Impact factor: 6.343

10.  Psychiatric functioning and quality of life in young patients with cardiac rhythm devices.

Authors:  Gregory Webster; Kathryn A Panek; Madelyn Labella; George Alexander Taylor; Kimberlee Gauvreau; Frank Cecchin; Maria Martuscello; Edward P Walsh; Charles I Berul; David R DeMaso
Journal:  Pediatrics       Date:  2014-03-24       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.